Inogen director granted 28,081 restricted shares

Inogen Inc director Glenn S. Boehnlein received an equity grant of 28,081 shares of Common Stock on June 5, 2026, at no cash cost, reported as acquired pursuant to a restricted stock unit award.

Rhea-AI Filing Summary

Inogen Inc director Glenn S. Boehnlein received an equity grant of 28,081 shares of Common Stock on June 5, 2026, at no cash cost, reported as acquired pursuant to a restricted stock unit award. The award will vest on the earlier of the one-year anniversary of the grant date or the day before Inogen’s next Annual Meeting of stockholders, subject to his continued service. Following this grant, Boehnlein directly holds 104,966 shares of Inogen common stock.

Insider Trade Summary

Grant/Award: 28,081 shares

Grant/Award 1 txn

Insider Boehnlein Glenn S

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	28,081	$0.00	$0.00

Holdings After Transaction: Common Stock — 104,966 shares (Direct)

Footnotes (1)

1. F1. The reported shares were acquired pursuant to a restricted stock unit award. Subject to the reporting person's continued service, the restricted stock unit award shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant.

Key Figures

Shares granted: 28,081 shares Grant price per share: $0.0000 per share Shares held after grant: 104,966 shares +1 more

4 metrics

Shares granted 28,081 shares Common Stock acquired on June 5, 2026 via restricted stock unit award

Grant price per share $0.0000 per share Reported acquisition price for the 28,081-share award

Shares held after grant 104,966 shares Total direct holdings of Common Stock following the transaction

Vesting schedule trigger One year from grant or before next Annual Meeting Award vests on earlier of these dates, subject to continued service

Key Terms

restricted stock unit award, Annual Meeting of the Issuer's stockholders, Grant, award, or other acquisition, Common Stock

4 terms

restricted stock unit award financial

"The reported shares were acquired pursuant to a restricted stock unit award."

A restricted stock unit award is a promise by a company to give an employee a specified number of company shares at a future date if certain conditions are met, such as staying with the company or hitting performance goals. For investors, these awards matter because they can increase the total number of shares outstanding when converted, diluting existing holders, and they align employees’ incentives with shareholders’ interests much like giving a rising bonus that becomes real only after conditions are satisfied.

Annual Meeting of the Issuer's stockholders financial

"the day prior to the date of the Annual Meeting of the Issuer's stockholders"

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

Common Stock financial

"security_title: Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Inogen Inc (INGN) report for Glenn S. Boehnlein?

Inogen Inc reported that director Glenn S. Boehnlein acquired 28,081 shares of Common Stock. The shares were granted as a restricted stock unit award, with no cash paid per share, and are subject to future vesting conditions tied to his continued service.

How many Inogen Inc (INGN) shares were granted to Glenn S. Boehnlein and at what price?

Glenn S. Boehnlein was granted 28,081 shares of Inogen Common Stock at a reported price of $0.0000 per share. This reflects a compensation-related equity award rather than an open-market purchase, as described in the Form 4 filing and accompanying footnote.

What are the vesting terms of Glenn S. Boehnlein’s restricted stock unit award at Inogen (INGN)?

The restricted stock unit award vests on the earlier of the one-year anniversary of the grant date or the day before Inogen’s next Annual Meeting of stockholders. Vesting is conditioned on Boehnlein’s continued service with the company through the applicable vesting date.

How many Inogen Inc (INGN) shares does Glenn S. Boehnlein hold after this Form 4 transaction?

After this equity award, Glenn S. Boehnlein directly holds 104,966 shares of Inogen Common Stock. This total, reported in the Form 4, includes the newly granted shares that were acquired pursuant to the restricted stock unit award, subject to the stated vesting terms.

Is Glenn S. Boehnlein’s Inogen (INGN) transaction an open-market purchase or a compensation grant?

The transaction is a compensation grant, not an open-market purchase. It is coded as a grant, award, or other acquisition, with 28,081 shares acquired at $0.0000 per share under a restricted stock unit award, contingent on future vesting conditions and continued service.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/09/2026 - 04:21 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Boehnlein Glenn S

(Last) (First) (Middle)

C/O INOGEN, INC.

500 CUMMINGS CENTER, SUITE 2800

(Street)

BEVERLY MASSACHUSETTS 01915

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Inogen Inc [ INGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/05/2026		A		28,081(1)	A	$0	104,966	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported shares were acquired pursuant to a restricted stock unit award. Subject to the reporting person's continued service, the restricted stock unit award shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant.

	/s/ Mary Wright, as Attorney-in-Fact	06/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)